Home | Patients | Webinars/Seminars
October 2021
Novel insights in inflammatory makers, AI, diagnostic tools and prediction of CV risk
This series consists of three educational videos. In the first lecture, Peter Libby discusses the role of inflammation in atherosclerosis. In the second lecture, Charalambos Antoniades talks about detecting residual cardiovascular risk using coronary CT angiography. The third and last video is a panel discussion with Peter Libby, Charalambos Antoniades and John Deanfield.
September 2021
Quantification of coronary inflammation using coronary CT angiography to improve patient risk prediction and stratification
Join Profs. Charalambos Antoniades, Steffen Petersen and Dr. Gianluca Pontone in this European Association of Cardiovascular Imaging webinar
July 2021
SCCT Symposium - Beyond plaque assessment: Fat Attenuation Index to personalize CV risk prediction
February 2021
Anti-inflammation heralds the future of CV medicine
From CANTOS to COLCOT to COPS to LoDoCo2: Dr. Ridker presents the lessons from these trials with anti-inflammatory treatment, in particular those with colchicine, in patients with residual inflammatory risk.
November 2017
Anti-inflammatory therapy in the prevention of cardiovascular disease
Prof. Libby discusses IL-1β as a target for atherosclerosis therapy, a strategy that was evaluated in the CANTOS trial, which tested the monoclonal antibody canakinumab
August 2017
The journey from vascular biology to the clinic: reducing inflammation lowers CV risk
Inflammation expert opinions aimed to provide guidance and perspectives on the implications of the CANTOS trial and other trials addressing inflammation in CVD. These expert views may help translate scientific findings to future clinical practice, by improving personalized CV risk management.